The Latest Breaking News from NICE

The technology industry has been on a roller coaster ride this year, with stocks running short of steam on investor worries about the Fed’s interest rate increases. However, given the industry’s solid long-term growth prospects, we think the stocks of fundamentally sound tech companies STMicroelectronics (STM), ACI Worldwide (ACIW), Axcelis…

Amid the uncertainties surrounding the U.S. economy, we think it could be wise to invest in quality Israeli stocks to cash in on the country’s favorable macroeconomic trends. Shares of Israel-based companies Teva (TEVA), ZIM (ZIM), and NICE (NICE) could be solid additions to one’s portfolio, given their fundamental strength.…

The former Manchester City captain, who spent two seasons in charge of Belgian side Anderlecht before leaving by mutual consent last month, is heavily linked with a move back to England

The winger was signed from Nice but has helped keep United in the Premier League three years running

Louise Swain-Hughes, 34, was diagnosed with cancer when she was six months pregnant and is now campaigning for a life-extending drug to be made available on NHS so she can spend more precious time with her son.

Nice has outlined what aspects of menopause care will be updated in upcoming guidance, including areas where more research is needed.

Han-Noah Massengo's contract situation and reported discussions in France indicate his days at Ashton Gate are increasingly numbered but a quick resolution appears unlikely

Bristol City starlet Han-Noah Massengo was offered a new contract towards the end of 2021 but it remains unsigned

‘Precious additional time before their disease progresses and more months to live and spend time with loved ones,’ says campaigner

Keytruda is for women with incurable secondary triple negative breast cancer and its aim is to slow disease progression.

Nice approves Keytruda, which with chemotherapy can lengthen survival of women with triple negative breast cancer